Navigation Links
Steerable Technologix LLC Announces Release of SurgiSteer Laparoscopic Instruments
Date:6/28/2010

JACKSONVILLE, Fla., June 28 /PRNewswire/ -- Steerable Technologix LLC announces the US release of its SurgiSteer™ laparoscopic instruments.  Developed from licensed technology from OrthoDynamix LLC, the SurgiSteer product line will exploit single port laparoscopic surgery with its steerable 5mm instrumentation. The Lap Grasper, Maryland Dissector and Endo Scissors, available in both free and ratchet handle configurations are simplistic in use versus competitive devices.  "Our design mission was to offer the most robust steerable laparoscopic instrument in the market while offering the surgeon a user friendly product with limited transitional barriers," said Bill Dennis, CEO.  "Our devices exhibit many steerable features that heretofore haven't been available to the surgeon such as high force opening jaws for blunt tissue dissection, strong jaw closing force for reliably driving suture needles, and a very intuitive bend and locking mechanism which eliminates excessive hand motion.  The SurgiSteer product portfolio will increase throughout the year to include RF devices," says Dennis.

Steerable instruments are necessary in one port surgery so as to create the proper orientation and/or triangulation for the surgeon while working through the umbilicus.

Steerable Technologix is a private equity funded medical device developer focused on disposable steerable instruments for general surgery, cardiovascular, spine, and ENT applications.

Steerable Technologix is a Gyrx LLC portfolio company.

SOURCE:  Steerable Technologix LLC

CONTACT:   Bill Dennis, CEO, bdennis@gyrx.com


'/>"/>
SOURCE Steerable Technologix LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016  The National Pharmaceutical ... joined the health policy research organization as its ... , MD, senior vice president and chief scientific ... representative on the NPC Board of Directors. ... that Mallinckrodt has joined us in support of ...
(Date:6/23/2016)... 23, 2016  Delcath Systems, Inc. (NASDAQ: ... focused on treatment of primary and metastatic liver cancers, ... education - www.againsttheodds.eu - has been awarded ... Awards. The website was developed ... and their families who are coping with the devastating ...
(Date:6/23/2016)... 2016 On Wednesday, June 22, 2016, ... 0.22%; the Dow Jones Industrial Average edged 0.27% lower to ... down 0.17%. Stock-Callers.com has initiated coverage on the following equities: ... (NASDAQ: AMAG ), IDEXX Laboratories Inc. (NASDAQ: ... ADRO ). Learn more about these stocks by accessing their ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
(Date:6/24/2016)... Gaithersburg, MD (PRWEB) , ... June 24, 2016 ... ... and protocols for human induced pluripotent stem (iPS) cells and other difficult to ... PluriQ™ G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... and infrastructure. Most providers, however, are unsure how to move forward, given the ... to define a path forward tailored to an organization’s specific needs. , PYA ...
Breaking Medicine News(10 mins):